Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CC4 Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

C4 Therapeutics, Inc.

$2.85Close · Oct 8, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $6.64M. Net result −$23.64M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $6.64M. Running result $6.64M. Revenue: $6.64M.
  • Cost of revenue: $0. Running result $6.64M.
  • Gross profit: $6.64M. Running result $6.64M.
  • Research and development: −$24.47M. Running result −$17.83M.
  • General and administrative: −$8.59M. Running result −$26.42M.
  • Operating income: −$26.42M. Running result −$26.42M.
  • Other income: $2.79M. Running result −$23.64M.
  • Pre-tax loss: −$23.64M. Running result −$23.64M.
  • Income tax benefit: $0. Running result −$23.64M.
  • Net loss: −$23.64M. Running result −$23.64M.